celecoxib has been researched along with astaxanthine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Byun, J; Day, CA; Jacob, RF; Lockwood, SF; Mason, RP; McNulty, HP; Walter, MF | 1 |
2 other study(ies) available for celecoxib and astaxanthine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cholesterol, LDL; Cyclooxygenase 2 Inhibitors; Heart; Humans; Lactones; Lipids; Membrane Lipids; Myocardium; Oxidation-Reduction; Phospholipids; Pyrazoles; Sulfonamides; Sulfones; Xanthophylls | 2006 |